Primrose Therapeutics Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Primrose Therapeutics General Information
Description
Operator of a biotechnology company. The company is focused on developing therapies for the treatment of Polycystic Kidney Disease (PKD).
Contact Information
Website
www.primrosetherapeutics.comCorporate Office
- 875 Third Avenue
- 3rd Floor
- New York, NY 10022
- United States
Corporate Office
- 875 Third Avenue
- 3rd Floor
- New York, NY 10022
- United States
Primrose Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Sep-2011 | Completed | Startup | |||
| 1. Angel (individual) | 13-Aug-2010 | Completed | Startup |
Primrose Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Primrose Therapeutics FAQs
-
When was Primrose Therapeutics founded?
Primrose Therapeutics was founded in 2010.
-
Where is Primrose Therapeutics headquartered?
Primrose Therapeutics is headquartered in New York, NY.
-
What industry is Primrose Therapeutics in?
Primrose Therapeutics’s primary industry is Biotechnology.
-
Is Primrose Therapeutics a private or public company?
Primrose Therapeutics is a Private company.
-
What is Primrose Therapeutics’s current revenue?
The current revenue for Primrose Therapeutics is .
-
How much funding has Primrose Therapeutics raised over time?
Primrose Therapeutics has raised $753K.
-
When was Primrose Therapeutics acquired?
Primrose Therapeutics was acquired on 01-Sep-2011.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
